Literature DB >> 9681837

The genetic analysis of cancer.

P L Pearson1, R B Van der Luijt.   

Abstract

During the past two decades an overwhelming amount of knowledge has been acquired on the molecular genetics of human cancer. It is now evident that cancer is essentially a genetic disease, arising from inherited and/or somatically acquired mutations at different genetic loci, and that tumourigenesis is a multistep process. Gene mapping studies of inherited cancer syndromes have resulted in the identification of many genes implicated in the initiation of tumours. Importantly, alterations of the same genes were also found to play a role in the development of common, non-familial tumours. The genes involved belong to distinct functional classes, and include proto-oncogenes and tumour suppressor genes, which are regulators of cellular growth and proliferation, cell adhesion and programmed cell death. Another class of cancer susceptibility genes consists of DNA repair genes, which are involved in maintaining genomic stability. In unravelling the genetic basis of cancer, the localization and identification of genes involved in tumourigenesis can be considered as the 'easy' part; determination of the normal physiological function of these genes and their precise role in tumourigenesis has proved to be much more difficult. In this review, we highlight some of the major breakthroughs in the field of cancer genetics, and discuss recent insights in the putative role of proto-oncogenes, tumour suppressor genes and DNA repair genes in the initiation and progression of cancer. Also, we point to some of the challenges to be faced in the coming years.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681837     DOI: 10.1046/j.1365-2796.1998.00343.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  11 in total

1.  Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction.

Authors:  T E Godfrey; S H Kim; M Chavira; D W Ruff; R S Warren; J W Gray; R H Jensen
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

2.  11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.

Authors:  S D Finkelstein; T Hasegawa; T Colby; S A Yousem
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

3.  Expression profiling of human tumors: the end of surgical pathology?

Authors:  M Ladanyi; W C Chan; T J Triche; W L Gerald
Journal:  J Mol Diagn       Date:  2001-08       Impact factor: 5.568

4.  Tumoral environment triggers transcript anomalies in established tumors: induction of altered gene expression and of aberrant, truncated and B2 repeat-containing gene transcripts.

Authors:  P Rottiers; M Desmedt; H Dooms; R Contreras; J Grooten
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

5.  Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.

Authors:  Arvind Raghavan; Rachel L Ogilvie; Cavan Reilly; Michelle L Abelson; Shalini Raghavan; Jayprakash Vasdewani; Mitchell Krathwohl; Paul R Bohjanen
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

6.  Regulation of CUG-binding protein 1 (CUGBP1) binding to target transcripts upon T cell activation.

Authors:  Daniel Beisang; Bernd Rattenbacher; Irina A Vlasova-St Louis; Paul R Bohjanen
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

7.  Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India.

Authors:  Abhijit Chakraborty; Ashis Mukhopadhyay; Deboshree Bhattacharyya; Chinmoy Kr Bose; Keya Choudhuri; Soma Mukhopadhyay; Jayasri Basak
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 8.  Methods for the molecular analysis of cancer. An overview.

Authors:  Ken Mills
Journal:  Mol Biotechnol       Date:  2003-02       Impact factor: 2.695

9.  CLDN1 expression in cervical cancer cells is related to tumor invasion and metastasis.

Authors:  Wei-Na Zhang; Wei Li; Xiao-Li Wang; Zheng Hu; Da Zhu; Wen-Cheng Ding; Dan Liu; Ke-Zhen Li; Ding Ma; Hui Wang
Journal:  Oncotarget       Date:  2016-12-27

Review 10.  The enigmatic helicase DHX9 and its association with the hallmarks of cancer.

Authors:  Chloe Gulliver; Ralf Hoffmann; George S Baillie
Journal:  Future Sci OA       Date:  2020-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.